Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer.

Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer. J Thorac Oncol. 2013 Jul; 8(7):915-22.

View in: PubMed

subject areas

Adenocarcinoma
Adult
Aged
Aged, 80 and over
Carcinoma, Large Cell
Carcinoma, Non-Small-Cell Lung
Carcinoma, Squamous Cell
Chemoradiotherapy
Cohort Studies
Combined Modality Therapy
Female
Follow-Up Studies
Humans
Lung Neoplasms
Male
Middle Aged
Neoadjuvant Therapy
Neoplasm Staging
Prognosis
Survival Rate

authors with profiles

Matthew Koshy
Andrew R. Howard
Ralph R. Weichselbaum
Mark K. Ferguson